Symbol | Exchange | Currency |
|---|
ABUJA, Nov 25 (Reuters) - Nigerian stocks climbed to aone-week high on Wednesday after the central bank expressedoptimism that it expected a recession in Africa's biggesteconomy to...
Oct 30 (Reuters) - May & Baker Nigeria PLC MAYBAKE.LG : * MAY & BAKER NIGERIA PLC - QTRLY GROUP REVENUE FROMCONTINUINGOPERATIONS 2.37 BILLION NAIRA VERSUS 1.86 BILLION NAIRA...
Feb 14 (Reuters) - May & Baker Nigeria PLC MAYBAKE.LG :* QTRLY GROUP REVENUE FROM CONTINUING OPERATIONS 2.17BILLIONNAIRA VERSUS 2 BILLION NAIRA* QTRLY GROUP PBT 228.4 MILLION...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Neutral | Buy | Strong Buy |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Buy | Strong Buy |
| Summary | Strong Sell | Strong Sell | Sell | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 23.70 | 23.70 | 23.50 | 0.00 | 0.00% | 52.68M | Lagos | |||
| 5.90 | 5.75 | 5.65 | +0.05 | +0.88% | 1.78M | Lagos | |||
| 19.90 | 19.90 | 19.90 | +1.20 | +6.42% | 95.38K | Lagos | |||
| 0.21 | 0.00 | 0.00 | +0.01 | +5.00% | 101.49K | Lagos | |||
| 45.00 | 45.10 | 45.00 | -1.00 | -2.17% | 1.23M | Lagos | |||
| 21.00 | 21.00 | 21.00 | 0.00 | 0.00% | 1.08M | Lagos | |||
| 28.80 | 28.80 | 28.80 | -0.70 | -2.37% | 219.53K | Lagos | |||
| 5.30 | 5.30 | 5.30 | 0.00 | 0.00% | 700.91K | Lagos | |||
| 71.30 | 71.30 | 71.30 | -7.60 | -9.63% | 109.56K | Lagos | |||
| 29.50 | 30.00 | 29.50 | -0.50 | -1.67% | 7.84M | Lagos | |||
| 7.40 | 7.45 | 7.30 | +0.05 | +0.68% | 5.48M | Lagos | |||
| 215.00 | 215.00 | 215.00 | 0.00 | 0.00% | 132.70K | Lagos | |||
| 8.25 | 8.45 | 8.25 | -0.20 | -2.37% | 11.34M | Lagos | |||
| 2.03 | 2.03 | 2.03 | 0.000 | 0.00% | 0.00 | Lagos | |||
| 22.25 | 22.30 | 22.25 | 0.00 | 0.00% | 0.00 | Lagos |
May & Baker Nigeria Plc is a Nigeria-based company, which is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. The Company's operating segments include Pharmaceuticals, Beverage and Foods. Its Pharmaceuticals segment is involved in the production and sale of human pharmaceuticals and human vaccines. Its Beverage segment is involved in the production of beverage drinks, including bottled water. Its Foods segment is involved in the production of package foods, including noodles. The Company offers pharmaceutical products for anti-diabetics, anti-hypertensive, anti-infectives, anti-malaria, analgesic, cough and cold, multivitamin and anxiolytics. Its anti-diabetic's products are sold under Diatab and Diamet brands. Its anti-hypertensive products are sold under Cardovasc Retard and Ramitace brands. Its food products are sold under the Mimee brand. Its beverages sector is engaged in the bottling of Lily brand of table water.